Zacharia Cheruvallath,Mallareddy Komandla,John David Lawson,Christopher McBride,Mingnam Tang
申请号：
US14426369
公开号：
US20150225405A1
申请日:
2013.09.06
申请国别(地区):
US
年份:
2015
代理人:
摘要：
Disclosed are compounds of Formula 1,and pharmaceutically acceptable salts thereof, wherein L, R1, R2, R3, R4, R5, R6, and R7 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating obesity and related diseases, disorders, and conditions associated with MetAP2.
